Literature DB >> 18642421

More on atypical fractures of the femoral diaphysis.

Paul Lee, Markus J Seibel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18642421

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.

Authors:  Pongthorn Narongroeknawin; Nivedita M Patkar; Bita Shakoory; Archana Jain; Jeffrey R Curtis; Elizabeth Delzell; Philip H Lander; Robert R Lopez-Ben; Michael J Pitt; Monika M Safford; David A Volgas; Kenneth G Saag
Journal:  J Clin Densitom       Date:  2011-11-09       Impact factor: 2.617

Review 2.  Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Authors:  M H Edwards; F C McCrae; S A Young-Min
Journal:  Osteoporos Int       Date:  2009-06-27       Impact factor: 4.507

3.  Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates.

Authors:  Frankie Leung; Tak-Wing Lau; Michael To; Keith Dip-Kei Luk; Annie Wai Chee Kung
Journal:  BMJ Case Rep       Date:  2009-03-05

Review 4.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 5.  [Mechanical thrombectomy for acute ischemic stroke : current evidence and open questions].

Authors:  S Meckel; C Taschner; S ElSheikh; C J Maurer; H Urbach
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

6.  Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies.

Authors:  P D Miller; R R Recker; S Harris; S Silverman; D Felsenberg; J Reginster; B-M Day; C Barr; D Masanauskaite
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

7.  Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.